Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Other Accumulated Expenses (2018 - 2019)

X4 Pharmaceuticals (XFOR) has disclosed Other Accumulated Expenses for 2 consecutive years, with $280000.0 as the latest value for Q2 2019.

  • For the quarter ending Q2 2019, Other Accumulated Expenses fell 36.65% year-over-year to $280000.0, compared with a TTM value of $280000.0 through Jun 2019, down 36.65%, and an annual FY2018 reading of $249000.0, changed N/A over the prior year.
  • Other Accumulated Expenses was $280000.0 for Q2 2019 at X4 Pharmaceuticals, up from $271000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $442000.0 in Q2 2018 and bottomed at $249000.0 in Q4 2018.